Lapsed Oct 21, 2026 on the fee record · Low confidence
20-year base term ends Sep 23, 2031
Third maintenance fee unpaid; grace period ended. The USPTO has not yet posted the lapse.
Held by GlaxoSmithKline LLC
Filed Jan 27, 2014 as application 14/164,414 · Granted Oct 21, 2014
Base term, 20 years from filing
Today
Lapsed Oct 21, 2026
2011
2031
Clock starts
Sep 23, 2011
Sep 23, 2011
No longer in force
Oct 21, 2026
Oct 21, 2026
Granted
Oct 21, 2014
Oct 21, 2014
Term would have run to
Sep 23, 2031
Sep 23, 2031
base term
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Sep 23, 2031: its 20-year base term, with no adjustment for prosecution delay. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 23, 2011, when application PCT/US2011/052857, the earliest non-provisional in its chain, was filed (this one was filed Jan 27, 2014) | Sep 23, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No fee event states this; the fee state is read from the payments the fee record holds; the fee record shows no payment for this window, and USPTO's status still reads "Patented Case" | lapsed Oct 21, 2026 | Low confidence |
| Computed term end | The steps above, in order | Oct 21, 2026 | Low confidence |
This family
| Application PCT/US2011/052857 | PCT application no patent term | no patent term |
| Application 13/876,853 | Abandoned not computed | not computed |
| US 8,674,090 | Lapsed on the fee record Mar 2026 | Mar 2026 |
| US 8,865,912 | this patent Oct 2026 | Oct 2026 |
| US 9,062,003 | In force Sep 2031 | Sep 2031 |
| US 9,156,797 | In force Sep 2031 | Sep 2031 |
| US 9,872,860 | Lapsed on the fee record Jan 2026 | Jan 2026 |
| US 10,314,845 | In force Sep 2031 | Sep 2031 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 10, 2014 Reel 32181, frame 555 | Qu, Junya; Rivero, Ralph A.; Sanchez, Robert; Tedesco, Rosanna | GlaxoSmithKline LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.